Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-26
2006-09-26
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07112569
ABSTRACT:
The present invention relates to a novel protein inhibiting β amyloid aggregation and a strain producing the protein, more precisely, to a novel protein inhibiting β amyloid aggregation, a gene coding the protein, aStreptomycessp. strain producing the protein and a therapeutic agent for neurodegenerative disorders containing the protein as an effective ingredient. The therapeutic agent of the present invention containing the protein inhibiting β amyloid aggregation as an effective ingredient can be effectively used for the prevention and the treatment of neurodegenerative disorders like Alzheimer's disease.
REFERENCES:
Dalakas Pharmacology & Therapeutics 102: 177-193 (2004) “The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile”.
Conway et al. Current Pharmaceutical Design 9: 427-447 (2003) “Emerging Beta-Amyloid Therapies for the Treatment of Alzheimer's Disease”.
Hwang, Sung Eun et al., Isolation of Streptomyces SP. KK565 as a Producer of β-Amyloid Aggregation Inhibitor, J. Microbiol. Biotechnol. (2003), 13(5), 809-814.
Klunk, William E. et al., Quantifying Amyloid β-Peptide (Aβ) Aggregation, Analytical Biochemistry 266, 66-76 (1999).
Spungin, Anya et al., Streptomyces Griseus Aminopeptidase Is . . . , Eur. J. Biochem. 183: 471-477 (89).
Iwata, Nobuhise et al., Identification of the Major Aβ 1-42- Degrading . . . , Nature Medicine, vol. 6, No. 2, Feb. 2000.
Eckman, Elizabeth A., Degradation of Alzheimer's . . . , The Journal of Biochemistry, vol. 276, No. 27, Issue of Jul. 6, pp. 24540-24548, 2001.
Zhu, Yinwen Judy et al., Fresh and Nonfibrillar Amyloid β . . . , The EASEB Journal, vol. 14, Jun. 2000: pp. 1244-1254.
Ahn Jo Sangmee
Jo In-ho
Kim Chang Jin
Kwon Ho Jeong
Park Jeong Eun
Desai Anand
Lucas & Mercanti LLP
National Institute of Health
Weber Jon
LandOfFree
Protein inhibiting aggregation of beta amyloid peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein inhibiting aggregation of beta amyloid peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein inhibiting aggregation of beta amyloid peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3569143